OM-RCA-01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OM-RCA-01, covering 2026-01-21 to 2026-01-21. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1 [Phase 1, Phase 2]